- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02106624
A Trial to Assess the Effect of High Nitrogen Intake in Critically Ill Patients
May 23, 2020 updated by: Ming Zhong, Shanghai Zhongshan Hospital
The Efficacy and Safety of High Nitrogen Intake in Critically Ill Patients: a Randomized and Controlled Trial
The patients with sepsis are in high risk of malnutrition, which could contribute to infection, difficulty in weaning from ventilators.
The investigators speculate whether nutrition therapy with high nitrogen could attenuate the malnutrition status and improve the outcome in these sepsis patients.
In this prospective Randomized Controlled Trial, the investigators aim to compare high nitrogen intake with conventional nitrogen supply which were recommended in guidelines.
Study Overview
Study Type
Interventional
Enrollment (Actual)
89
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Division of Critical Care Medicine: Zhongshan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- need mechanical ventilation for more than 2 days
- mean blood pressure more than 60mmHg
- predicted ICU stay more than 7 days
- tolerance of parenteral or enteral nutrition
Exclusion Criteria:
- irreversible status of primary disease
- any history of malnutrition before enrollment
- history of steroid cortisol administration
- severe liver dysfunction (Child-Pugh Score C)
- pregnancy
- refuse to enrollment
- re-admission to ICU and has been enrolled during former admission to ICU
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Nitrogen
In this arm, daily nitrogen supply is as much as 2.5-3.0 g per kilogram (lean mass weight)
|
Nitrogen supply could be administered through amino acid in parenteral nutrition, proteins in enteral nutrition.
|
|
Active Comparator: conventional nitrogen
In this arm, daily nitrogen supply is 1.2-1.5g
per kilogram (lean mass weight) as recommended by ESPEN guideline
|
Nitrogen supply could be administered through amino acid in parenteral nutrition, proteins in enteral nutrition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
all cause mortality
Time Frame: 28 days
|
28 days
|
|
all cause mortality
Time Frame: 90 days
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration on ventilators
Time Frame: patients enrolled will be followed for the duration of mechanical ventilation, an expcected average of 4 weeks
|
patients enrolled will be followed for the duration of mechanical ventilation, an expcected average of 4 weeks
|
|
|
ICU stay
Time Frame: patients enrolled will be followed for length of ICU stay, an expected average of 6 weeks
|
patients enrolled will be followed for length of ICU stay, an expected average of 6 weeks
|
|
|
infection incidence rate
Time Frame: 28 days
|
Details of infection includes pneumonia, catheter-related blood stream infection, urinary tract infect, et al.
Diagnosis of infection accords to symptoms, lab tests, imaging measurements and bacterial cultures.
|
28 days
|
|
Liver function and renal function
Time Frame: on 1st. day, 3rd. day, 7th. day, 14th. day, 21st. day, 28th. day after enrollment
|
Liver function is assessed through serum bilirubin and liver enzyme, renal function is assessed through serum urea nitrogen and creatinine.
|
on 1st. day, 3rd. day, 7th. day, 14th. day, 21st. day, 28th. day after enrollment
|
|
diameter of midpoint of musculus rectus femoris
Time Frame: on 28th. day or endpoint of the trial
|
diameter of the muscle is measured with percutaneous ultrasound
|
on 28th. day or endpoint of the trial
|
|
serum concentration of albumin, pre albumin, retinaldehyde binding protein, transferrin
Time Frame: on 7th. day , 14th. day, 21st. day, 28th. day after enrollment
|
on 7th. day , 14th. day, 21st. day, 28th. day after enrollment
|
|
|
change of body composition
Time Frame: on 7th.day, 14th.day, 21st.dat, 28th.day after enrollment
|
on 7th.day, 14th.day, 21st.dat, 28th.day after enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2015
Primary Completion (Actual)
January 1, 2020
Study Completion (Actual)
May 1, 2020
Study Registration Dates
First Submitted
March 30, 2014
First Submitted That Met QC Criteria
April 3, 2014
First Posted (Estimate)
April 8, 2014
Study Record Updates
Last Update Posted (Actual)
May 27, 2020
Last Update Submitted That Met QC Criteria
May 23, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HiNiCi
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critically Ill
-
Third Military Medical UniversityNot yet recruiting
-
Niveus Medical, Inc.Terminated
-
Mahidol UniversityNot yet recruiting
-
China Medical University HospitalRecruitingCritically Ill PatientsTaiwan
-
Hospital Sao DomingosCompletedCritically Ill PatientsBrazil
-
Ain Shams UniversityUnknownCritically-ill PatientsEgypt
-
Hôpital Edouard HerriotCompletedCritically Ill PatientsFrance
-
Johannes Gutenberg University MainzUnknown
-
Kaohsiung Veterans General Hospital.CompletedCritically Ill PatientsTaiwan
-
St. Antonius HospitalCompletedCritically Ill Patients
Clinical Trials on nitrogen supply
-
Medical University InnsbruckCompletedThoracic Surgery | Mechanical Ventilation | One-Lung VentilationAustria
-
Beth Israel Deaconess Medical CenterBoston Children's HospitalCompletedLower Urinary Tract SymptomsUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownBrain Death | ComaChina
-
London School of Hygiene and Tropical MedicineCompletedDiarrhea | CholeraCongo, The Democratic Republic of the
-
Hamilton Health Sciences CorporationInstitute for Clinical Evaluative Sciences; Population Health Research InstituteCompleted
-
London School of Hygiene and Tropical MedicineEmory University; Bill and Melinda Gates Foundation; KIIT University, Bhubaneswar... and other collaboratorsUnknownDiarrhea | Stunting | Soil-transmitted Helminth Infection | Enteric InfectionUnited Kingdom
-
National University, SingaporeTsao Foundation SingaporeActive, not recruiting
-
Institut National de la Recherche AgronomiqueCompletedSustainable LifestylesFrance
-
University of MichiganNot yet recruitingType 2 Diabetes | Hypertension (HTN)
-
Equip, LesothoUnited States Agency for International Development (USAID); Elizabeth Glaser... and other collaboratorsUnknown